Additionally, positive staining for GATA-3 and GCDFP-15 confirmed the breast origin of the metastatic carcinoma, while negative staining for markers such as PAX-8 and CDX2 helped exclude primary ovarian and gastrointestinal origins, respectively [14,15]. This evidence concerns the gene CDX2 and metastatic carcinoma.